OIP5 and cancer: Several lncRNAs have been linked to various types of cancer; for example, terminal differentiation-induced non-coding RNA (TINCR), lncRNA-p21, lncRNA OIP5-AS1, lncRNA UCA1 and Hox transcript antisense intergenic RNA (HOTAIR) have been identified as potential therapeutic targets for cancer treatment (11, 12).